Reversal effect of mifepristone on adriamycin resistance in human breast cancer cell line MCF-7/ADM in vitro and in vivo

Journal of Central South University (Medical Sciences)

Volumn 35, Issue 6, 2010, Pages 576-583

  Huang, Junhui ^a   Zhang, Yi ^b   Huang, Yuting ^c   Zhang, Xibei ^c   Xiao, Jia ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

^c Central South University   (China)

Author keywords

Adriamycin; Adriamycin resistance in human breast carcinoma cell line MCF 7; Mifepristone; Multidrug resistance; Reverse

Indexed keywords

DOXORUBICIN; MIFEPRISTONE;

ANIMAL; ARTICLE; BREAST TUMOR; CANCER TRANSPLANTATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; MOUSE; NUDE MOUSE; PATHOLOGY; RANDOMIZATION; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICE; MICE, NUDE; MIFEPRISTONE; NEOPLASM TRANSPLANTATION; RANDOM ALLOCATION;

EID: 77954773412     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1672-7347.2010.06.007     Document Type: Article

References (13)

1. L.I Huiyan, MIAO Xinpu, HOU Mei. The state and development in research of multidrug resistance in tumor [J]. West China Medical Journal, 2008, 3 (5): 1226-1227.
2. Li D Q, Wang Z B, Bai J. et al. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SCG7901/VCR by antiprogestin drug mifepristone [J]. World Gastroenterol, 2004, 10(12): 1722-1725.
3. Payen L, FAU - Delugin L, Courtois A, et al. Reversal of MRP-mediated multidrug resistance in human lung cancer cells by the antiprogestatin drug RU486 [J]. Biochem Biophys Res Conunun, 1999, 258(3): 513-518.
4. KE Peiqi, ZHENG Wenting, ZHU Yunxiao, et al. The influence of increasing and multidrug resistance in human ovarian cancer cell line SK-OV-3 by MIF [J]. Journal of Sun Yat-Sen University. Medical Sciences, 2004, 3 (s): 223-225.
5. LIU Yong, CHEN Chunyan, KONG Dexiao, et al. Study of establishment of K562/HHT cell line and reversal of multidrug resistance by antiprogestin drug mifepristone [J]. Chinese Journal of Pathophysiology, 2007, 23 (11): 2168-2172.
6. Carbonell Esteve J L, Acosta R. Mifepristone for the treatment of uterine leiomyomas: a randomized controlled trial [J]. Obstet Gynecol, 2008, 112(5): 1029-1036.
7. Elizabeth M F, Alica A G. Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity [J]. Cancer cell international, 2009, 9(4): 1-13.
8. Burger H, Foekens J A, Look MP, et al. RNA expression of breast cancer resistance protein, lung resistance - related protein, multidrug resistance - associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response [J]. Clin Cancer Res, 2003, 9:827-836.
9. Liu C F, Chen C L, Liu Y S. Ceramide in apoptotic signaling and anticancer therapy [J]. Curr Med Chem, 2006, 13(14) :1609.
10. KONG Dexiao, CHEN Chunyan. Study of reversal of mifepristone on K562/A02 cell lines [J], Chinese Journal of Hematology, 2007, 28 (8): 555-559.
11. Assaraf Y G. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis [J]. Drug Resistant Update, 2006, 9 (4): 227-246.
12. Perez-Tomas R. Multidrug-resistance: retrospect and prospects in anti-cancer drug treatment [J]. Curr Med Chem, 2006, 13(16): 1859-1876.
13. Freeburg E M, Goyeneche A A. Mifepristone modulates glucosylceramide synthase expression and reverse multidrug resistance in ovarian cancer cells [J]. Int J Oncol, 2009, 34 (3) :743-755.